GlaxoSmithKline's ViiV Healthcare Wins First FDA OK for Two-Drug HIV Regimen Post author:Sam Post published:November 21, 2017 Post category:BioPharma HIV patients have a new maintenance drug in their arsenal of medication. Source: BioSpace You Might Also Like Pfizer's $15B Consumer Health Biz May be on GlaxoSmithKline's Shopping List October 25, 2017 Mettler-Toledo To Exhibit At Annual Conference In Fort Worth, TX October 8, 2017 Can-Fite BioPharma Reports Second Quarter 2017 Financial Results & Provides Clinical Update August 31, 2017
Can-Fite BioPharma Reports Second Quarter 2017 Financial Results & Provides Clinical Update August 31, 2017
